Spots Global Cancer Trial Database for glutamine
Every month we try and update this database with for glutamine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma | NCT01983969 | Advanced Cancer... Lymphoma | Azacitidine Vorinostat Gemcitabine Busulfan Melphalan Dexamethasone Caphosol Glutamine Pyridoxine Rituximab | 15 Years - 65 Years | M.D. Anderson Cancer Center | |
| Glutamine Plus L. Reuteri Prevents TKI Therapy-diarrhea in Patients With NSCLC | NCT05852990 | Non-Small Cell ... | Glutamine plus ... | 18 Years - 80 Years | Instituto Nacional de Cancerologia de Mexico | |
| Nutrition for Colorectal Cancer Patients and Neutrophil Functions | NCT01831310 | Malnutrition Colorectal Canc... | Standard (Kabiv... Standard-Glutam... Standard-Omega ... Standard-glutam... | 50 Years - 70 Years | Kocaeli University | |
| Oral Glutamine and Mucositis of Head and Neck Cancer Patients Undergoing Radiation | NCT02282839 | Head and Neck C... Mucositis | Glutamine Placebo | 20 Years - | Taichung Veterans General Hospital | |
| Oral Glutamine and Mucositis of Head and Neck Cancer Patients Undergoing Radiation | NCT02282839 | Head and Neck C... Mucositis | Glutamine Placebo | 20 Years - | Taichung Veterans General Hospital | |
| Glutamine for the Prevention of Radiation Toxicity in Subjects Conserving Therapy | NCT02012608 | Breast Cancer | Glutamine Placebo | 18 Years - | University of Arkansas | |
| Perioperative Glutamine Supplementation and Cachexia | NCT05023499 | Glutamine; Meta... Cachexia | SYMPT-X Glutami... | 20 Years - | National Taiwan University Hospital | |
| Study of the Glutaminase Inhibitor CB-839 in Leukemia | NCT02071927 | Acute Myeloid L... Acute Lymphocyt... | CB-839 CB-Aza | 18 Years - | Calithera Biosciences, Inc | |
| A Cohort Study of Beta-Glucan or Beta-Glucan Compound in Metastatic Cancers | NCT04710290 | Metastatic Canc... Chemotherapy | Beta-Glucan Glutamine Immunoglobuin Corn starch | 20 Years - | E-DA Hospital | |
| Oral Glutamine and Thoracic/Upper Aerodigestive Tumors Radiation Toxicity | NCT05054517 | Biopsy Confirme... | Glutamine | - | National and Kapodistrian University of Athens | |
| KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, Nonsquamous NSCLC | NCT04265534 | Non-Small Cell ... Non-squamous No... Non-Squamous No... KEAP1 Gene Muta... NRF2 Gene Mutat... NFE2L2 Gene Mut... | Telaglenastat Carboplatin Che... Pemetrexed Chem... Pembrolizumab I... Placebo Folic acid 400 ... Vitamin B12 100... Dexamethasone 4... | 18 Years - | Calithera Biosciences, Inc | |
| Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer | NCT00003170 | Cancer | glutamine placebo | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Study of Glutamine as Prophylaxis for Irinotecan Induced Diarrhea | NCT00255229 | Metastatic Colo... | Glutamine Placebo | 18 Years - | AHS Cancer Control Alberta | |
| Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer | NCT00003170 | Cancer | glutamine placebo | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Carfilzomib/SAHA Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant in Myeloma | NCT02114502 | Myeloma | Carfilzomib SAHA Gemcitabine Busulfan Melphalan Stem Cell Trans... Palifermin Dexamethasone Caphosol Glutamine Pyridoxine | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Study of the Glutaminase Inhibitor CB-839 in Hematological Tumors | NCT02071888 | Non-Hodgkin's L... Multiple Myelom... Waldenstrom's M... Other B-cell NH... T-cell NHL | CB-839 CB-839 and low ... CB-839, pomalid... | 18 Years - | Calithera Biosciences, Inc | |
| Glutamine in Treating Side Effects in Children Who Are Undergoing Stem Cell Transplantation | NCT00003898 | Oral Complicati... Unspecified Chi... | glutamine | 1 Year - 21 Years | Roswell Park Cancer Institute | |
| Belinostat Combined With Azacitidine/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Refractory or Relapsed Lymphoma | NCT02701673 | Lymphoma | Busulfan Caphosol Glutamine Pyridoxine Belinostat Azacitidine Gemcitabine Melphalan Stem Cell Trans... | 15 Years - 65 Years | M.D. Anderson Cancer Center | |
| Clinical Benefits of Preoperative Nutrition Support With Enteral Immune-enhancing Formulas in Surgical Oncology | NCT01032512 | CANCER | SUPPORTAN + GLU... NO PREOPERATIVE... | - 80 Years | University of Chile | |
| Study of Glutamine as Prophylaxis for Irinotecan Induced Diarrhea | NCT00255229 | Metastatic Colo... | Glutamine Placebo | 18 Years - | AHS Cancer Control Alberta | |
| A Trial of Glutamine to Prevent Oxaliplatin Neurotoxicity and a Pharmacokinetic Analysis of Oxaliplatin | NCT01157039 | Colorectal Carc... Neoplasms, Colo... Colorectal Canc... Colorectal Tumo... Metastasis | Glutamine | 18 Years - | AHS Cancer Control Alberta | |
| Glutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving Bortezomib | NCT01783522 | Chemotherapeuti... Multiple Myelom... Peripheral Neur... | glutamine quality-of-life... placebo | 18 Years - | Case Comprehensive Cancer Center | |
| Glutamine PET Imaging in LAM | NCT04388371 | Lymphangioleiom... | Glutamine | 18 Years - | Vanderbilt University Medical Center | |
| KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, Nonsquamous NSCLC | NCT04265534 | Non-Small Cell ... Non-squamous No... Non-Squamous No... KEAP1 Gene Muta... NRF2 Gene Mutat... NFE2L2 Gene Mut... | Telaglenastat Carboplatin Che... Pemetrexed Chem... Pembrolizumab I... Placebo Folic acid 400 ... Vitamin B12 100... Dexamethasone 4... | 18 Years - | Calithera Biosciences, Inc | |
| Efficacy of Glutamine in Management of Radiation Mucositis | NCT05856188 | Radiation-Induc... | Glutamine | 20 Years - 70 Years | Ain Shams University | |
| Belinostat Combined With Azacitidine/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Refractory or Relapsed Lymphoma | NCT02701673 | Lymphoma | Busulfan Caphosol Glutamine Pyridoxine Belinostat Azacitidine Gemcitabine Melphalan Stem Cell Trans... | 15 Years - 65 Years | M.D. Anderson Cancer Center | |
| A Trial of Glutamine to Prevent Oxaliplatin Neurotoxicity and a Pharmacokinetic Analysis of Oxaliplatin | NCT01157039 | Colorectal Carc... Neoplasms, Colo... Colorectal Canc... Colorectal Tumo... Metastasis | Glutamine | 18 Years - | AHS Cancer Control Alberta | |
| Study of the Glutaminase Inhibitor CB-839 in Leukemia | NCT02071927 | Acute Myeloid L... Acute Lymphocyt... | CB-839 CB-Aza | 18 Years - | Calithera Biosciences, Inc | |
| Study of CB-839 in Combination w/ Paclitaxel in Participants of African Ancestry and Non-African Ancestry With Advanced Triple Negative Breast Cancer (TNBC) | NCT03057600 | Triple Negative... TNBC - Triple-N... | Paclitaxel CB-839 | 18 Years - | Calithera Biosciences, Inc | |
| Efficacy of an Oral Formula in Prevention of Anti-cancer Therapy Side Effects | NCT00455247 | Digestive Cance... | Glutamine | 18 Years - | Société des Produits Nestlé (SPN) | |
| Oral Glutamine and Mucositis of Head and Neck Cancer Patients Undergoing Radiation | NCT02282839 | Head and Neck C... Mucositis | Glutamine Placebo | 20 Years - | Taichung Veterans General Hospital | |
| Glutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving Bortezomib | NCT01783522 | Chemotherapeuti... Multiple Myelom... Peripheral Neur... | glutamine quality-of-life... placebo | 18 Years - | Case Comprehensive Cancer Center | |
| Perioperative Glutamine Supplementation and Cachexia | NCT05023499 | Glutamine; Meta... Cachexia | SYMPT-X Glutami... | 20 Years - | National Taiwan University Hospital | |
| Effects of Oral L-Glutamine in Head and Neck Cancer Patients During Radiotherapy | NCT03015077 | Head and Neck C... | oral glutamine placebo Radiotherapy | 20 Years - 75 Years | Kaohsiung Medical University Chung-Ho Memorial Hospital | |
| The Impact of Preoperative Oral Glutamine Intake on the Immunocompetence and Outcomes of Malnourished Patients Undergoing Major Abdominal Surgery Due to Malignancies | NCT01552291 | Malnourishment Gastrointestina... | Glutamine Placebo | - | Insel Gruppe AG, University Hospital Bern | |
| Randomized Trial of Glutamine in Patients With Mucositis or Esophagitis | NCT01952847 | Advanced Cancer... | Placebo Glutamine Questionnaires | 17 Years - | M.D. Anderson Cancer Center | |
| Glutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving Bortezomib | NCT01783522 | Chemotherapeuti... Multiple Myelom... Peripheral Neur... | glutamine quality-of-life... placebo | 18 Years - | Case Comprehensive Cancer Center | |
| A Cohort Study of Beta-Glucan or Beta-Glucan Compound in Metastatic Cancers | NCT04710290 | Metastatic Canc... Chemotherapy | Beta-Glucan Glutamine Immunoglobuin Corn starch | 20 Years - | E-DA Hospital | |
| CB-839 With Everolimus vs. Placebo With Everolimus in Participants With Renal Cell Carcinoma (RCC) | NCT03163667 | Clear Cell Rena... | Placebo CB-839 everolimus | 18 Years - | Calithera Biosciences, Inc | |
| The Role of Glutamine for Preventing Oxaliplatin-Induced Peripheral Neuropathy | NCT02024191 | Peripheral Neur... | Glutamine | 20 Years - 65 Years | Ankara Education and Research Hospital | |
| The Role of Glutamine for Preventing Oxaliplatin-Induced Peripheral Neuropathy | NCT02024191 | Peripheral Neur... | Glutamine | 20 Years - 65 Years | Ankara Education and Research Hospital | |
| CB-839 With Everolimus vs. Placebo With Everolimus in Participants With Renal Cell Carcinoma (RCC) | NCT03163667 | Clear Cell Rena... | Placebo CB-839 everolimus | 18 Years - | Calithera Biosciences, Inc | |
| Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer | NCT00003170 | Cancer | glutamine placebo | 18 Years - | Alliance for Clinical Trials in Oncology | |
| A Trial of Glutamine to Prevent Oxaliplatin Neurotoxicity and a Pharmacokinetic Analysis of Oxaliplatin | NCT01157039 | Colorectal Carc... Neoplasms, Colo... Colorectal Canc... Colorectal Tumo... Metastasis | Glutamine | 18 Years - | AHS Cancer Control Alberta | |
| Oral Glutamine in the Prevention of Oxaliplatin-induced Neurotoxicity | NCT01087658 | Colorectal Neop... | Glutamine Calcium and Mag... | 18 Years - | Sanofi | |
| Study of the Glutaminase Inhibitor CB-839 in Solid Tumors | NCT02071862 | Solid Tumors Triple-Negative... Non Small Cell ... Renal Cell Carc... Mesothelioma Fumarate Hydrat... Succinate Dehyd... Succinate Dehyd... Tumors Harborin... Tumors Harborin... | CB-839 Pac-CB CBE CB-Erl CBD CB-Cabo | 18 Years - | Calithera Biosciences, Inc | |
| Glutamine Plus L. Reuteri Prevents TKI Therapy-diarrhea in Patients With NSCLC | NCT05852990 | Non-Small Cell ... | Glutamine plus ... | 18 Years - 80 Years | Instituto Nacional de Cancerologia de Mexico | |
| Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype | NCT02589145 | Lymphoma | Lenalidomide Vorinostat Gemcitabine Busulfan Melphalan Rituximab Dexamethasone Caphosol Glutamine Pyridoxine Enoxaparin Stem Cell Trans... Palifermin | 15 Years - 65 Years | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
